Pharmacovigilance Compliance Report submission; MHRA’s Risk Based Compliance Programme
pharmafile | September 20, 2011 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | PV, Wainwright Associates
A new version of the MHRA pharmacovigilance Compliance Report (Good Pharmacovigilance Practice Questionnaire) has been released by the MHRA.
Submission of a Compliance Report is part of the MHRA’s Risk Based Inspection Programme (with companies who do not submit a report being allocated a higher risk score, and therefore having a higher chance of being subject to an MHRA inspection). Submission of a Compliance Report is recommended every 2 years, with this year’s submission deadline being 4th November 2011.
If you would like to discuss your pharmacovigilance requirements, please contact us at enquiries@wainwrightassociates.co.uk or telephone +44 (0)1628 530554.
Related Content
Submission of labels and leaflets in the UK
The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels …
On-going Medicine evaluation Information to be published by European Medicines Agency
Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and …
MHRA Inspections of CROs
In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU …